Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2-Reference-Cited by-同舟云学术

Metabolic tumor heterogeneity analysis by F-18 FDG PET/CT predicts mediastinal lymph node metastasis in non-small cell lung cancer patients with clinically suspected N2

Published:2018-09 Issue: Volume:106 Page:145-149
ISSN:0720-048X
Container-title:European Journal of Radiology
language:en
Short-container-title:European Journal of Radiology

Author:

Pahk Kisoo,Chung Jae Ho,Yi Eunjue,Kim Sungeun^ORCID,Lee Sung Ho

Funder

Korea University grant, Korea

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference29 articles.

1. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications;Andre;J. Clin. Oncol.,2000

2. A clinical prediction rule to estimate the probability of mediastinal metastasis in patietnes with non-small cell lung cancer;Shafazand;J. Thorac. Oncol.,2006

3. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer;Roth;Lung cancer,1998

4. Postoperative radiotherapy for pathologic N2 non-small-cell lung cancer treated with adjuvant chemotherapy: a review of the National Cancer data Base;Robinson;J. Clin. Oncol.,2015

5. Reduced lung-cancer mortality with low-dose computed tomographic screening;National Lung Screening Trial Research Team;N. Engl. J. Med.,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coefficient of Variation in Metastatic Lymph Nodes Determined by 18F-FDG PET/CT in Patients with Advanced NSCLC: Combination with Coefficient of Variation in Primary Tumors;Cancers;2024-01-09

2. Impact of preoperative [18F]FDG PET/CT vs. contrast-enhanced CT in the staging and survival of patients with clinical stage I and II non-small cell lung cancer: a 10-year follow-up study;Annals of Nuclear Medicine;2023-12-25

3. Heterogeneity of Glycolytic Phenotype Determined by 18F-FDG PET/CT Using Coefficient of Variation in Patients with Advanced Non-Small Cell Lung Cancer;Diagnostics;2023-07-22

4. A nomogram based on 18F-fluorodeoxyglucose PET/CT and clinical features to predict epidermal growth factor receptor mutation status in patients with lung adenocarcinoma;Quantitative Imaging in Medicine and Surgery;2022-11

5. Predictive value of multiple metabolic and heterogeneity parameters of 18F-FDG PET/CT for EGFR mutations in non-small cell lung cancer;Annals of Nuclear Medicine;2022-01-27